Turning Point Therapeutics Inc
Biotechnology
Healthcare
TPTX
49.70 M shares
NASDAQ US
traded
16 Aug 2022
listed
yes
open
75.99
52 week high
81.99
high
76.01
52 week low
24.32
low
75.98
growth
-1.96 %
previous Close
75.49
P/E ratio
-31
market cap
3.73 B
div yield
0
usd
Jun 2022
qoq
revenue
119 K
-72.26 %
net incoming
-123.09 M
-65.34 %
eps
-2.48 %
-65.33 %
eps surprise
-45.88 %
net profit margin
-103435.29 %
-86082.00 %
operating incoming
-124.36 M
-65.96 %
net change in cash
-19.39 M
83.62 %
cash on hand
290 M
-6.26 %
cost of revenue
0.00 %
top top